Every one of those 1 sits in a single category, market-trends. Alltrna is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 3.3 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Ipsen Pharma
Every one of those 1 sits in a single category, market-trends. Alltrna is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 3.3 for the broader beat in this window. At 5, the average consequence score sits below the same-window beat average of 5.9. We currently track 1 Healthcare story that mention Ipsen Pharma, all published on March 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 38 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Ipsen Pharma. Shared-story counts are live from our verified record — not editorial picks.
Ipsen has appointed industry veteran Michelle C. Werner as Executive Vice President and President of North America, effective immediately. Werner, who joins from Flagship Pioneering and Alltrna, will oversee the company's largest geographic market as it accelerates its specialty care strategy in oncology and rare diseases.
Ipsen Pharma is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.